Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
05/09/2002 | US20020055142 Major intrinsic protein (MIP)-like polynucleotides, polypeptides, and antibodies |
05/09/2002 | US20020055138 Staphylococcal GTPase obg nucleotide sequence encoding Staphylococcal GTP-binding protein |
05/09/2002 | US20020055135 Isolation of carotenoid crystals from microbial biomass |
05/09/2002 | US20020055128 Measuring binding of a candidate compound to the polypeptide (or to the cells or membranes bearing the polypeptide) or a fusion protein by means of a label associated with candidate compound, measuring binding, testing signal generated |
05/09/2002 | US20020054887 Toxin has at least one amino acid change and is substantially non-lethal compared with wild type SPE-A toxin; for vaccines |
05/09/2002 | US20020054868 Bacterial strain, processes plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
05/09/2002 | US20020054867 A probiotic formulation of Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799); containing at least one volatile fraction (VF) of a plant extract |
05/09/2002 | US20020054866 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
05/09/2002 | CA2363287A1 Process for preparing a fermentation medium from a renewable raw material |
05/08/2002 | EP1203822A1 Extracellular polysaccharide from Gluconacetobacter spp |
05/08/2002 | EP1203817A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
05/08/2002 | EP1203816A1 Amyloid beta protein agglutination controlling factor |
05/08/2002 | EP1203811A2 Production of metabolites of interest by co-culture of plant cells and non-plant cells |
05/08/2002 | EP1203775A2 Lymphocyte chemoattractant factor and uses thereof |
05/08/2002 | EP1203084A1 Microencapsulated nitric oxide synthase source |
05/08/2002 | EP1203081A2 Human intracellular signaling molecules |
05/08/2002 | EP1203027A1 Enhanced stability and performance of cells and cell components |
05/08/2002 | EP1203024A1 Human tumor necrosis factor receptors tr13 and tr14 |
05/08/2002 | EP1203023A1 Pgpcr-3 polypeptides and dna sequences thereof |
05/08/2002 | EP1203022A1 Novel genetic sequences encoding steroid and juvenile hormone receptor polypeptides and uses therefor |
05/08/2002 | EP1203020A1 Modulation of human sodium channels in dorsal root ganglia |
05/08/2002 | EP1203018A1 26 human prostate and prostate cancer associated proteins |
05/08/2002 | EP1203016A2 Proteases and protease inhibitors |
05/08/2002 | EP1203015A2 Human chaperone proteins |
05/08/2002 | EP1203013A1 Kinase blocking polypeptides and uses thereof |
05/08/2002 | EP1203005A2 25 human secreted proteins |
05/08/2002 | EP1202817A1 Fermentation post-sterile additive delivery method and apparatus |
05/08/2002 | EP1202744A2 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
05/08/2002 | EP0721505B1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
05/08/2002 | EP0708653B1 Assay and reagents for identifying anti-proliferative agents |
05/08/2002 | EP0662136B1 Cleaning compositions containing novel alkaline proteases |
05/08/2002 | EP0627932B1 Antibody construct |
05/08/2002 | DE10112107A1 Preparing L-amino acids, particularly L-threonine, for use in pharmaceutical and in food industries, comprises employing the microorganisms of the Enterobacteriaceae family for fermentation in which the poxB gene is attenuated |
05/08/2002 | DE10053224A1 Verfahren zur Exposition von Peptiden und Polypeptiden auf der Zelloberfläche von Bakterien A process for the exposure of peptides and polypeptides on the cell surface of bacteria |
05/08/2002 | CN1348492A Pseudomycin production by i(pseudomonas syringae) |
05/08/2002 | CN1348491A Method for culturing a basidiomycetous fungus in a liquid culture medium |
05/08/2002 | CN1348490A Method for the purification, recovery, and sporulation of cysts and oocysts |
05/08/2002 | CN1348464A Compositions and methods using lactadherin or variants thereof |
05/08/2002 | CN1348463A Immunological herpes simplex virus antigens and methods for use thereof |
05/08/2002 | CN1348000A Alpha-amylase with high production capacity |
05/08/2002 | CN1347982A Arginine repressor defective bacterial strain of rodlike bacteria and process for producing L-arginine |
05/08/2002 | CN1347981A Pseudomonas stutzeri Zh9944 and its screening method and bacterial wilt preventing and controlling microbial prepn |
05/08/2002 | CN1347635A Production process of gastrodia elata seed germinating strain for cultivation |
05/08/2002 | CN1084388C Process for producing optically active compound |
05/07/2002 | USH2023 Streptococcus pneumoniae sequence GrpE |
05/07/2002 | US6384300 Invertase inhibitor |
05/07/2002 | US6384203 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
05/07/2002 | US6384198 Methods for inhibiting the production of HIV-1 retrovirus using monoclonal antibodies and Fv specific for CD2 antigen |
05/07/2002 | US6384186 Cyclic dodecapeptide and process for the preparation thereof |
05/07/2002 | US6383810 Rapidly dissolving nutritionally complex stable dry powder which can be prepared in variable bulk quantities and can be sterilized by ionizing or ultraviolet irradiation; agglomerating a dry powder nutritive media with a solvent |
05/07/2002 | US6383800 Inoculating wood with meruliporia incrassata and/or antrodia radiculosa, lignocellulosic substrates and nutrient supplements; aerating and hydrating the wood to remediate the preservative |
05/07/2002 | US6383799 Culturing tremella mesenterica in submerged culture on nutrient media, then isolating biomass by alcohol precipitation |
05/07/2002 | US6383797 Bioremediation; pollution control |
05/07/2002 | US6383793 Human osteoclast-derived cathepsin |
05/07/2002 | US6383787 Nucleotide sequence that encodes a non-ribosomal peptide synthetase; for recombinant production of anticarcinogenic agents |
05/07/2002 | US6383786 Method for producing α-hydroxy acid from α-hydroxy nitrile using nitrilase |
05/07/2002 | US6383782 Amino acid sequences of monocyte chemoattractant protein-1; antiinflammatory agents; treatment of rheumatoid arthritis, multiple sclerosis and atherosclerosis |
05/07/2002 | US6383780 2786, a novel human aminopeptidase |
05/07/2002 | US6383779 Glycoprotein VI and uses thereof |
05/07/2002 | US6383778 Nucleotide sequence which codes for receptor that binds to phenylthiocarbamide ligand; for taste modulating compounds for use in food and drug industries |
05/07/2002 | US6383777 Methods and compositions for high yield production of eukaryotic proteins |
05/07/2002 | US6383745 Methods of screening for anti-microbial utilizing aarC and compositions thereof |
05/07/2002 | US6383739 Drug screening by isolating blood cells then cd8+ cells from donors, culturing with compound for 3 days, culturing in with interleukin-2, detecting immunodeficiency-virus suppressing lymphokine expression, then further analysis |
05/07/2002 | US6383496 Recombinant vaccines comprising immunogenic attenuated bacteria having RPOS positive phenotype |
05/07/2002 | US6383486 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
05/07/2002 | US6383474 Carotenoid preparation |
05/07/2002 | US6383379 Water pollution control; aeration and settling tanks |
05/03/2002 | CA2360907A1 Production of interesting metabolites by co-culture of plant and non-plant cells |
05/02/2002 | WO2002034945A2 Estrogen receptor alpha variants and methods of detection thereof |
05/02/2002 | WO2002034940A2 Methods for screening compounds that modulate lipid metabolism |
05/02/2002 | WO2002034922A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
05/02/2002 | WO2002034921A2 FERMENTATIVE PRODUCTION OF D-p-HYDROXYPHENYLGLYCINE AND D-PHENYLGLYCINE |
05/02/2002 | WO2002034919A1 Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
05/02/2002 | WO2002034914A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
05/02/2002 | WO2002034913A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
05/02/2002 | WO2002034911A1 Mfq-114, a human ajuba like protein |
05/02/2002 | WO2002034909A2 Engineered chimera of hiv protein fragments and uses thereof |
05/02/2002 | WO2002034906A2 Method for exposing peptides and polypeptides on the cell surface of bacteria |
05/02/2002 | WO2002034903A2 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications |
05/02/2002 | WO2002034899A2 Tec kinase assay |
05/02/2002 | WO2002034895A2 Novel aggrecanase molecules |
05/02/2002 | WO2002034884A1 Streptomyces kasugaensis inhibiting the fungal pathogens of plant |
05/02/2002 | WO2002034879A2 Method for introducing antisense oligonucleotides into eucaryotic cells |
05/02/2002 | WO2002034783A2 Transmembrane proteins |
05/02/2002 | WO2002034773A2 Streptococcal genes |
05/02/2002 | WO2002034772A2 Novel compounds |
05/02/2002 | WO2002034680A1 Reclaiming water and usable brine concentrate from domestic sewage |
05/02/2002 | WO2002034288A2 Vaccine for treating allergy |
05/02/2002 | WO2002012537A3 Mutant trichosanthin |
05/02/2002 | WO2002010206A3 Nucleotide sequences which code for the metf gene |
05/02/2002 | WO2002008253A3 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY |
05/02/2002 | WO2002004523A3 Artificial antibody polypeptides |
05/02/2002 | WO2002002636A3 Membrane associated protein zupari |
05/02/2002 | WO2001098330A3 A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS |
05/02/2002 | WO2001090147A3 Long wavelength engineered fluorescent proteins |
05/02/2002 | WO2001083555A3 Pain signaling molecules |
05/02/2002 | WO2001077137A9 Albumin fusion proteins |
05/02/2002 | WO2001070771A3 Acute neuronal induced calcium binding protein type 1 ligand |
05/02/2002 | WO2001068824A3 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
05/02/2002 | WO2001068708A3 Human and humanized fap-alpha-specific antibodies |